| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
23,458 |
17,522 |
$3.17M |
| J9035 |
Injection, bevacizumab, 10 mg |
12,743 |
9,598 |
$873K |
| 92134 |
|
36,324 |
30,353 |
$829K |
| J0178 |
Injection, aflibercept, 1 mg |
1,952 |
1,518 |
$769K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
11,723 |
11,645 |
$289K |
| 92235 |
|
5,695 |
4,576 |
$227K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,201 |
6,736 |
$198K |
| 92250 |
|
5,239 |
5,176 |
$126K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,526 |
2,523 |
$117K |
| 67228 |
|
512 |
470 |
$90K |
| J7999 |
Compounded drug, not otherwise classified |
3,689 |
2,998 |
$79K |
| 92133 |
|
4,377 |
4,315 |
$78K |
| 92083 |
|
4,136 |
4,124 |
$68K |
| 92242 |
|
677 |
673 |
$62K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
113 |
93 |
$27K |
| 68761 |
|
506 |
258 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
87 |
87 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
118 |
118 |
$2K |
| 76512 |
|
66 |
58 |
$2K |
| 76514 |
|
62 |
62 |
$929.80 |